Cooperative Cardiovascular Disease Research Network (RECAVA);Red Temática de Investigación Cooperativa en Enfermedades Cardiovasculares (RECAVA)

Revista Espanola de Cardiologia

Volumn 61, Issue 1, 2008, Pages 58-65

  García Dorado, David ^b   Castro Beiras, Alfonso ^b   Díez, Javier ^b   Gabriel, Rafael ^b   Gimeno Blanes, Juan R ^b   De Landázuri, Manuel Ortiz ^b   Sánchez, Pedro L ^b   Fernández Avilés, Francisco ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b NONE

Author keywords

Formation; Investigational networks; Traslational medicine

Indexed keywords

BUDGET; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL PRACTICE; CLINICAL RESEARCH; EARLY DIAGNOSIS; EPIDEMIOLOGICAL DATA; HEALTH CARE; HEALTH CARE COST; HEALTH CARE FACILITY; MEDICAL LITERATURE; MEDICAL RESEARCH; PROPHYLAXIS; REVIEW; SPAIN; TECHNOLOGY; TRAINING; ARTICLE; HUMAN; ORGANIZATION AND MANAGEMENT;

BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; HUMANS; SPAIN;

EID: 41949136120     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13114958     Document Type: Article

References (23)

1. Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006;27:1610-9.
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. Plos Med. 2006;3:2011-30.
3. Marincola FM. Translational medicine: A two-way road. J Transl Med. 2003;1:1.
4. Gray ML, Bonventre JV. Training PhD researchers to translate science to clinical medicine: closing the gap from the other side. Nat Med. 2002;8:433-6.
5. Archer SL. The making of a physician-scientist - the process has a pattern: lessons from the lives of Nobel laureates in medicine and physiology. Eur Heart J. 2007;28:510-4.
6. Lazaro A, Gallego-Delgado J, Osende JI, Egido J, Vivanco F. Analysis of antihypertensive drugs in the heart of animal models: a proteomic approach. Methods Mol Biol. 2007;357:45-58.
7. Rey M, Valenzuela-Fernández A, Urzainqui A, Yáñez- Mó M, Pérez-Martínez M, Penela P, et al. Myosin II is involved in the endocytosis of CXCR4 induced by SDF-1. J Cell Sci. 2007;120:1126-33.
8. López B, González A, Beaumont J, Querejeta R, Larman M, Díez J. Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure. J Am Coll Cardiol. 2007;50:859-67.
9. De las Heras N, Ruiz-Ortega M, Miana M, Rupérez M, Sanz-Rosa D, Aragoncillo P, et al. Interactions between CTGF and aldosterone in vascular and renal damage in spontaneously hypertensive rats. J Hypertens. 2007;3:629-38.
10. González A, Ravassa S, Loperena I, López B, Beaumont J, Querejeta R, et al. Association of depressed cardiac gp130-mediated anti-apoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure. J Hypertens. 2007;25:2148-57.
11. Ravassa S, González A, López B, Querejeta R, Larman M, Díez J. Upregulation of myocardial annexin A5 is associated with systolic dysfunction in arterial hypertension independently of apoptosis. Eur Heart J 2007;doi:10.1093/eurheartj/ehm370.
12. Blanco-Colio LM, Martín-Ventura JL, Muñoz-García B, Orbe J, Páramo JA, et al. Identification of soluble tumor necrosis factorlike weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:916-22.
13. Corral J, Hernández-Espinosa D, Soria JM, González-Conejero R, Ordoñez A, González-Porras JR, et al. Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis. Blood. 2007;109:4258-63.
14. Verdeguer F, Castro C, Kubicek M, Pla M, Vila-Caballer M, Vinué A, et al. Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation. Cardiovasc Res. 2007;76:340-50.
15. Serrano H, Jorge I, Martínez-Acedo P, Navarro PJ, Pérez-Hernández D, Miró Casas E, et al. Quantitative proteomics of mitochondrial membrane proteins by sodium dodecyl sulphate polycrylamide gel electrophoresis, 16O/18O stable isotope labeling and linear ion trap mass spectrometry. Proteomica. 2007;0:29-34.
16. Fernandez-Aviles F, Alonso JJ, Pena G, Blanco J, Alonso-Briales J, Lopez-Mesa J, et al. Primary angioplasty vs. early routine postfibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur Heart J. 2007;28:949-60.
17. Barderas MG, Tunon J, Darde VM, De la Cuesta F, Duran MC, Jimenez-Nacher JJ, et al. Circulating human monocytes in the acute coronary syndrome express a characteristic proteomic profile. J Proteome Res. 2007;6:876-86.
18. Mas S, Touboul D, Brunelle A, Aragoncillo P, Egido J, Laprevote O, et al. Lipid cartography of atherosclerotic plaque by cluster-TOF-SIMS imaging. Analyst. 2007;132:24-6.
19. Sanchez PL, Santos JL, Kaski JC, Cruz I, Arribas A, Villacorta E, et al; Grupo AORTICA (Grupo de Estudio de la Estenosis Aortica). Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol. 2006;97:90-3.
20. San Roman JA, Lopez J, Vilacosta I, Luaces M, Sarria C, Revilla A, et al. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med. 2007;120:e1-7.
21. Manzano MC, Vilacosta I, San Román JA, Aragoncillo P, Sarriá C, López D, et al. Síndrome coronario agudo en la endocarditis infecciosa. Rev Esp Cardiol. 2007;60:24-31.
22. San Roman JA, Sanz-Ruiz R, Ortega JR, Perez-Paredes M, Rollan MJ, Munoz AC, et al. Safety and predictors of complications with a new accelerated dobutamine stress echocardiography protocol. J Am Soc Echocardiogr. 2007. Disponible en: http://dx.doi.org/10.1016/j.echo.2007.05.025.
23. Monserrat L, Hermida-Prieto M, Fernandez X, Rodriguez I, Dumont C, Cazon L, et al. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur Heart J. 2007;28:1953-61.